OBJECTIVES: To evaluate fetal growth in pregnancies complicated by placenta previa with or without placenta accreta spectrum (PAS) disorder, compared with in pregnancies with a low-lying placenta. METHODS: This was a multicenter retrospective cohort study of singleton pregnancies complicated by placenta previa with or without PAS disorder, for which maternal characteristics, ultrasound-estimated fetal weight and birth weight were available. Four maternal-fetal medicine units participated in data collection of diagnosis, treatment and outcome. The control group comprised singleton pregnancies with a low-lying placenta (0.5-2 cm from the internal os). The diagnosis of PAS and depth of invasion were confirmed at delivery using both a predefine...
Gamal A Kassem,1 Ali K Alzahrani21Department of Obstetrics and Gynecology, 2Neonatal Intensive Care ...
OBJECTIVES: To describe the maternal and perinatal outcomes in patients with Placenta Previa and pr...
Objectives: To predict placental accreta spectrum (PAS) in patients with placenta previa (PP) evalua...
Objectives: To evaluate fetal growth in pregnancies complicated by placenta previa, both with and wi...
Introduction: Incidence of placenta previa is 3-5per 1000 pregnancies. Placenta previa includes: i) ...
PubMed ID: 22427011Aim: To examine the association between placenta previa and adverse perinatal out...
PURPOSE: To compare maternal and neonatal outcomes of prenatally diagnosed versus undiagnosed cases ...
Introduction: To study the association between placental pathology and neonatal birthweight and outc...
Objective To estimate the prevalence and incidence of placenta previa complicated by placenta accret...
Introduction: The purpose of the study was to evaluate the differences in individual histopathologic...
Recent population studies have shown that placenta accreta spectrum (PAS) disorders remain undiagnos...
Objectives: To evaluate the diagnostic performance of third trimester ultrasound for the diagnosis o...
Objective To estimate the prevalence and incidence of placenta previa complicated by placenta accret...
Objective—To estimate the association between placenta previa and abnormal fetal growth. Study Desig...
International audienceObjective To describe and compare the characteristics of women with placenta a...
Gamal A Kassem,1 Ali K Alzahrani21Department of Obstetrics and Gynecology, 2Neonatal Intensive Care ...
OBJECTIVES: To describe the maternal and perinatal outcomes in patients with Placenta Previa and pr...
Objectives: To predict placental accreta spectrum (PAS) in patients with placenta previa (PP) evalua...
Objectives: To evaluate fetal growth in pregnancies complicated by placenta previa, both with and wi...
Introduction: Incidence of placenta previa is 3-5per 1000 pregnancies. Placenta previa includes: i) ...
PubMed ID: 22427011Aim: To examine the association between placenta previa and adverse perinatal out...
PURPOSE: To compare maternal and neonatal outcomes of prenatally diagnosed versus undiagnosed cases ...
Introduction: To study the association between placental pathology and neonatal birthweight and outc...
Objective To estimate the prevalence and incidence of placenta previa complicated by placenta accret...
Introduction: The purpose of the study was to evaluate the differences in individual histopathologic...
Recent population studies have shown that placenta accreta spectrum (PAS) disorders remain undiagnos...
Objectives: To evaluate the diagnostic performance of third trimester ultrasound for the diagnosis o...
Objective To estimate the prevalence and incidence of placenta previa complicated by placenta accret...
Objective—To estimate the association between placenta previa and abnormal fetal growth. Study Desig...
International audienceObjective To describe and compare the characteristics of women with placenta a...
Gamal A Kassem,1 Ali K Alzahrani21Department of Obstetrics and Gynecology, 2Neonatal Intensive Care ...
OBJECTIVES: To describe the maternal and perinatal outcomes in patients with Placenta Previa and pr...
Objectives: To predict placental accreta spectrum (PAS) in patients with placenta previa (PP) evalua...